SCHEMBL7225910

SCHEMBL7225910

[C-]#[N+]/C(C(=O)OC)=C(\Br)c1cccc(F)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 1/20 0.39
PKM P14618 1/20 0.35
NPC1 O15118 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
P2RX7 Q99572 3/20 0.33
ALDH1A1 P00352 3/20 0.33
RAB9A P51151 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH2 P05091 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
ALOX15 P16050 1/20 0.32
CES2 O00748 1/20 0.32
BCHE P06276 1/20 0.32
CES1 P23141 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774612 0.82 GAA (0.42) SMN1; SMN2ALDH1A1RAB9AKMT2AMAPT
SCHEMBL1181190 0.72 PDK2 (0.51) CYP11B1CYP11B2ALDH1A1KMT2AKDM4E
SCHEMBL3493650 0.71 TSHR (0.44) NPC1SMN1; SMN2RAB9AKMT2AKDM4E
SCHEMBL3493043 0.71 TSHR (0.44) NPC1SMN1; SMN2RAB9AKMT2AKDM4E
SCHEMBL5125735 0.67 CASP1 (0.42) ALDH1A1KMT2AHPGDCES2CES1
SCHEMBL5125736 0.67 CASP1 (0.42) ALDH1A1KMT2AHPGDCES2CES1
SCHEMBL31146017 0.66 KMT2A (0.49) CYP11B1CYP11B2SMN1; SMN2P2RX7ALDH1A1
SCHEMBL8242079 0.66 KMT2A (0.49) CYP11B1CYP11B2SMN1; SMN2P2RX7ALDH1A1
SCHEMBL7080990 0.66 CES2 (0.61) CYP11B1CYP11B2SMN1; SMN2ALDH1A1RAB9A
SCHEMBL1742047 0.66 GAA (0.67) CYP11B1CYP11B2SMN1; SMN2P2RX7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6670373-B1 Inhibiting resistant neoplasms where the resistance is conferred by multidrug resistance protein; N-3,4,5-trimethoxyphenyl-3-(3-azidomethyl-isoxazolo(4,5-c) -1,2-dihydro-6-chloro-quinolin-2-on-1-yl)phenylacetamide ELI LILLY AND COMPANY 2003-12-30 US disclosed